Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed CFO Appointed director Inv. presentation
|
Medite Cancer Diagnostics, Inc. (MDIT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/23/2018 |
4
| ABELES JOHN H (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Acquired 40,000 shares
@ $0 Bought 266,667 shares
@ $0.075, valued at
$20k
|
|
10/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/30/2018 |
4
| Lewis William Austin IV (10% Owner) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Bought 1,100,000 shares
@ $0.075, valued at
$82.5k
|
|
07/30/2018 |
4
| Von Rump Stephen L. (CEO / CFO) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Bought 133,333 shares
@ $0.075, valued at
$10k
|
|
07/20/2018 |
3
| Von Rump Stephen L. (CEO) has filed a Form 3 on Medite Cancer Diagnostics, Inc. |
07/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/10/2018 |
4
| ABELES JOHN H (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Bought 400,000 shares
@ $0.075, valued at
$30k
|
|
07/05/2018 |
4
| Lewis William Austin IV (10% Owner) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Bought 8,000,000 shares
@ $0.075, valued at
$600k
Bought 1,333,334 shares
@ $0.075, valued at
$100k
|
|
05/08/2018 |
4
| FORTUNOFF GREGORY (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Bought 1,333,334 shares
@ $0.75, valued at
$1M
Bought 100,000 convertible notes
@ $0.075, valued at
$7.5k
|
|
05/08/2018 |
3
| FORTUNOFF GREGORY (Director) has filed a Form 3 on Medite Cancer Diagnostics, Inc. |
05/04/2018 |
3
| KANTER JOEL S (Director) has filed a Form 3 on Medite Cancer Diagnostics, Inc. |
02/12/2018 |
4
| Lewis William Austin IV (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Bought 10,666,667 shares
@ $0.075, valued at
$800k
Unknown transaction of 1,333,333 shares
@ $0.075, valued at
$100k
Bought 312,579 warrants
@ $0.5, valued at
$156.3k
Granted 600,000 options
@ $0.5, valued at
$300k
|
|
02/12/2018 |
3/A
| Lewis William Austin IV (Director) has filed a Form 3/A on Medite Cancer Diagnostics, Inc. |
02/12/2018 |
3
| Lewis William Austin IV (Director) has filed a Form 3 on Medite Cancer Diagnostics, Inc. |
11/16/2017 |
4
| Weisman Susan (CFO) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Granted 200,000 shares
@ $0.81, valued at
$162k
|
|
11/16/2017 |
3
| Weisman Susan (CFO) has filed a Form 3 on Medite Cancer Diagnostics, Inc. |
03/21/2017 |
3
| Goehausen Eric Michael (Director) has filed a Form 3 on Medite Cancer Diagnostics, Inc. |
10/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2015 |
4
| Ott Michael Egbert (President and COO) has filed a Form 4 on Medite Cancer Diagnostics, Inc.
Txns:
| Bought 156,250 shares
@ $0 Bought 156,250 shares
@ $0 |
|
05/28/2013 |
4
| Carbonell Xavier (Director) has filed a Form 4 on CytoCore Inc
Txns:
| Granted 919,234 shares
@ $0.0155, valued at
$14.2k
|
|
05/22/2013 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc |
06/28/2012 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc
Txns:
| Bought 1,301,353 shares
@ $0.02, valued at
$26k
|
|
03/08/2012 |
3
| Ocana Augusto (Director) has filed a Form 3 on CytoCore Inc |
03/08/2012 |
3
| Scimia Mauro (Director) has filed a Form 3 on CytoCore Inc |
02/16/2012 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc
Txns:
| Bought 2,187,500 shares
@ $0.015, valued at
$32.8k
|
|
05/05/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/05/2009 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc
Txns:
| Bought 10,000 shares
@ $0.55, valued at
$5.5k
Bought 11,000 shares
@ $0.52, valued at
$5.7k
Bought 30,000 shares
@ $0.51, valued at
$15.3k
Bought 7,500 shares
@ $0.55, valued at
$4.1k
Bought 40,000 shares
@ $0.56, valued at
$22.4k
Bought 25,000 shares
@ $0.48, valued at
$12k
Bought 22,000 shares
@ $0.44, valued at
$9.7k
Bought 1,000 shares
@ $0.45, valued at
$450 Bought 5,000 shares
@ $0.45, valued at
$2.3k
Bought 18,000 shares
@ $0.44, valued at
$7.9k
Bought 10,000 shares
@ $0.44, valued at
$4.4k
|
|
12/04/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/04/2008 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc |
|
|